Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study

Bacsur Péter and Matuz Mária and Resál Tamás and Miheller Pál and Szamosi Tamás and Schäfer Eszter and Sarlós Patrícia and Iliás Ákos and Szántó Kata Judit and Rutka Mariann and Bálint Anita and Milassin Ágnes and Fábián Anna and Bor Renáta and Szepes Zoltán and Molnár Tamás and Farkas Klaudia: Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 15 (January-December). pp. 1-18. ISSN 1756-283X (2022)

[thumbnail of Bacsur.pdf]
Preview
Text
Bacsur.pdf - Published Version

Download (730kB) | Preview
Item Type: Journal Article
Journal or Publication Title: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY
Date: 2022
Volume: 15
Number: January-December
Number of Pages: 18
Page Range: pp. 1-18
ISSN: 1756-283X
Faculty/Unit: Faculty of Pharmacy
Albert Szent-Györgyi Medical School
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 33532273
DOI azonosító: https://doi.org/10.1177/17562848221144349
Date Deposited: 2023. Jan. 02. 11:46
Last Modified: 2023. Feb. 02. 13:51
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/25882
Web of Science® Times Cited: 1 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year